BACKGROUND: Minute ventilation/CO(2) production (VE/Vco(2)) slope is an index determined by cardiopulmonary exercise testing, which incorporates pertinent cardiac, pulmonary, and skeletal muscle physiology into a substantive composite assessment. The VE/Vco(2) slope has many applications, including utility as a well-validated prognostic gauge for patients with heart failure (HF). In this study, we combine VE/Vco(2) slope with systolic blood pressure, creating a novel index that we labeled ventilatory power. Ventilatory power links the combined physiology inherent in the VE/Vco(2) slope to peripheral pressure, adding an additional dimension pertinent to HF assessment. Whereas the related concept of circulatory power links peak oxygen consumption with peak systolic blood pressure as a prognostic index, we hypothesized that ventilatory power would provide greater prognostic discrimination than VE/Vco2 slope, peak oxygen consumption, and circulatory power for patients with systolic HF. METHODS AND RESULTS: Patients with systolic HF (left ventricular ejection fraction ≤35%) underwent symptom-limited cardiopulmonary exercise testing as part of routine management and were followed for up to 4 years for major cardiac events (mortality, left ventricular assist device implantation, and heart transplantation). Eight hundred seventy-five patients with HF (left ventricular ejection fraction, 26±9%; mean age, 55±14) were studied. Cardiopulmonary exercise testing indices peak oxygen consumption, VE/Vco(2) slope, circulatory power, and ventilatory power were all predictive of cardiac events (P<0.001). Multivariate analysis demonstrated that ventilatory power was the strongest indicator of prognosis. CONCLUSIONS: Although circulatory power and traditional cardiopulmonary exercise testing parameters can be used to predict prognosis among patients with HF, ventilatory power provides relatively greater prognostic discrimination and may constitute a relatively more useful composite tool.
BACKGROUND: Minute ventilation/CO(2) production (VE/Vco(2)) slope is an index determined by cardiopulmonary exercise testing, which incorporates pertinent cardiac, pulmonary, and skeletal muscle physiology into a substantive composite assessment. The VE/Vco(2) slope has many applications, including utility as a well-validated prognostic gauge for patients with heart failure (HF). In this study, we combine VE/Vco(2) slope with systolic blood pressure, creating a novel index that we labeled ventilatory power. Ventilatory power links the combined physiology inherent in the VE/Vco(2) slope to peripheral pressure, adding an additional dimension pertinent to HF assessment. Whereas the related concept of circulatory power links peak oxygen consumption with peak systolic blood pressure as a prognostic index, we hypothesized that ventilatory power would provide greater prognostic discrimination than VE/Vco2 slope, peak oxygen consumption, and circulatory power for patients with systolic HF. METHODS AND RESULTS:Patients with systolic HF (left ventricular ejection fraction ≤35%) underwent symptom-limited cardiopulmonary exercise testing as part of routine management and were followed for up to 4 years for major cardiac events (mortality, left ventricular assist device implantation, and heart transplantation). Eight hundred seventy-five patients with HF (left ventricular ejection fraction, 26±9%; mean age, 55±14) were studied. Cardiopulmonary exercise testing indices peak oxygen consumption, VE/Vco(2) slope, circulatory power, and ventilatory power were all predictive of cardiac events (P<0.001). Multivariate analysis demonstrated that ventilatory power was the strongest indicator of prognosis. CONCLUSIONS: Although circulatory power and traditional cardiopulmonary exercise testing parameters can be used to predict prognosis among patients with HF, ventilatory power provides relatively greater prognostic discrimination and may constitute a relatively more useful composite tool.
Authors: Jonathan Myers; Ross Arena; Frederick Dewey; Daniel Bensimhon; Joshua Abella; Leon Hsu; Paul Chase; Marco Guazzi; Mary Ann Peberdy Journal: Am Heart J Date: 2008-09-16 Impact factor: 4.749
Authors: Sharon Ann Hunt; William T Abraham; Marshall H Chin; Arthur M Feldman; Gary S Francis; Theodore G Ganiats; Mariell Jessup; Marvin A Konstam; Donna M Mancini; Keith Michl; John A Oates; Peter S Rahko; Marc A Silver; Lynne Warner Stevenson; Clyde W Yancy Journal: Circulation Date: 2009-03-26 Impact factor: 29.690
Authors: P Palange; S A Ward; K-H Carlsen; R Casaburi; C G Gallagher; R Gosselink; D E O'Donnell; L Puente-Maestu; A M Schols; S Singh; B J Whipp Journal: Eur Respir J Date: 2007-01 Impact factor: 16.671
Authors: W S Colucci; J P Ribeiro; M B Rocco; R J Quigg; M A Creager; J D Marsh; D F Gauthier; L H Hartley Journal: Circulation Date: 1989-08 Impact factor: 29.690
Authors: William T Abraham; Gregg C Fonarow; Nancy M Albert; Wendy Gattis Stough; Mihai Gheorghiade; Barry H Greenberg; Christopher M O'Connor; Jie Lena Sun; Clyde W Yancy; James B Young Journal: J Am Coll Cardiol Date: 2008-07-29 Impact factor: 24.094
Authors: G D Back; M R Oliveira; P F Camargo; C L Goulart; C R Oliveira; K W Wende; J C Bonjorno Junior; R F Arbex; F R Caruso; R Arena; A Borghi-Silva Journal: Braz J Med Biol Res Date: 2022-07-13 Impact factor: 2.904
Authors: Artur Haddad Herdy; Luiz Eduardo Fonteles Ritt; Ricardo Stein; Claudio Gil Soares de Araújo; Mauricio Milani; Romeu Sérgio Meneghelo; Almir Sérgio Ferraz; Carlos Hossri; Antonio Eduardo Monteiro de Almeida; Miguel Morita Fernandes-Silva; Salvador Manoel Serra Journal: Arq Bras Cardiol Date: 2016-11 Impact factor: 2.000
Authors: Erik H Van Iterson; Courtney M Wheatley; Sarah E Baker; Thomas P Olson; Wayne J Morgan; Eric M Snyder Journal: PLoS One Date: 2016-12-20 Impact factor: 3.240
Authors: Polliana B Dos Santos; Rodrigo P Simões; Cássia da L Goulart; Meliza G Roscani; Renan S Marinho; Patrícia Faria Camargo; Renata F Arbex; Guilherme Casale; Cláudio R Oliveira; Renata G Mendes; Ross Arena; Audrey Borghi-Silva Journal: Int J Chron Obstruct Pulmon Dis Date: 2021-02-03
Authors: Polliana B Dos Santos; Rodrigo P Simões; Cássia L Goulart; Guilherme Peixoto Tinoco Arêas; Renan S Marinho; Patrícia F Camargo; Meliza G Roscani; Renata F Arbex; Claudio R Oliveira; Renata G Mendes; Ross Arena; Audrey Borghi-Silva Journal: Sci Rep Date: 2022-01-31 Impact factor: 4.379